Holen Sie sich die Stockscreener-App
8.32
5.60%
-0.4939
Finanzdaten der Sensei Biotherapeutics Inc-Aktie (SNSE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Operating Expenses |
28.43%
5.206
|
7.274 | 7.787 | 8.73 | 8.142 |
| Interest Income/Expense |
23.08%
0.01
|
0.013 | 0.024 | 0.028 | 0.031 |
| Operating Income/Loss |
28.43%
-5.206
|
-7.274 | -7.787 | -8.73 | -8.142 |
| Income/Loss From Continuing Operations Before Tax |
28.09%
-4.936
|
-6.864 | -7.142 | -7.992 | -17.30 |
| Income Tax Expense/Benefit |
-
|
- | - | - | -9.89 |
| Income/Loss From Continuing Operations After Tax |
28.09%
-4.936
|
-6.864 | -7.142 | -7.992 | -7.414 |
Net Income/Loss
|
28.09%
-4.936
|
-6.864 | -7.142 | -7.992 | -7.414 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
95.00%
1.2609
|
25.19 | 25.10 | 25.05 | -0.9899 |
| Diluted Average Shares |
95.00%
1.2609
|
25.19 | 25.10 | 25.05 | -0.9899 |
| Basic Earnings Per Share |
1,348%
-3.91
|
-0.27 | -0.28 | -0.32 | -0.30 |
| Diluted Earnings Per Share |
1,348%
-3.91
|
-0.27 | -0.28 | -0.32 | -0.30 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):